search
Back to results

Microbiome-Directed Food for Sustained Recovery From Acute Malnutrition (MDF)

Primary Purpose

Acute Malnutrition in Childhood

Status
Not yet recruiting
Phase
Not Applicable
Locations
Burkina Faso
Study Type
Interventional
Intervention
Microbiome-directed food - MAM
Ready-to-use supplementary food (RUSF)
Locally available food
Microbiome-directed food (MDF) - SAM
Ready-to-use therapeutic food (RUTF)
Sponsored by
Institut de Recherche en Sciences de la Sante, Burkina Faso
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Malnutrition in Childhood

Eligibility Criteria

6 Months - 23 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age between 6 and 23 months
  • Moderate wasting: WHZ < -2 and ≥ -3 or MUAC < 125 mm and ≥ 115mm or - Severe wasting: WHZ < -3 or MUAC < 115 mm

Exclusion Criteria:

  • Bilateral pitting edema
  • Not eating/lack of appetite
  • Current illness medical complications requiring inpatient treatment
  • Presence of any congenital abnormality or underlying chronic disease that may affect growth or risk of infection
  • Known contraindication/hypersensitivity/allergy to MDCF of RUSF ingredients (chickpea flour, soy flour, banana, peanut)
  • Relapse from MAM treatment or transfer from SAM treatment
  • Children recently (<2 months) or enrolled in a nutrition program
  • Residence outside the study area

Sites / Locations

  • LANOU Hermann Bienou

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Experimental

Active Comparator

Active Comparator

Experimental

Active Comparator

Arm Label

Microbiome-directed food (MDF) - MAM

Ready-to-use supplementary food (RUSF)

Locally available Food

Microbiome-directed food (MDF) - SAM

Ready-to-use therapeutic food (RUTF)

Arm Description

Each (MAM) child will receive a daily ration of MDF corresponding to his weight, for maximum 12 weeks of supplementation

Each (MAM) child will receive a daily ration of MDF corresponding to his weight, for maximum 12 weeks of supplementation

Each (MAM) child will receive a basket of food ingredients to prepare a complementary food at home. The quantity of ingredients is based on child's weight. The food is given a maximum duration of 12 weeks.

Each (SAM) child will receive a daily ration of MDF corresponding to his weight, for maximum 12 weeks of supplementation.

Each (SAM) child will receive a daily ration of RUTF corresponding to his weight, for maximum 12 weeks of supplementation

Outcomes

Primary Outcome Measures

Programmatic recovery defined by Weight-for-height (WHZ) ≥ - 2 z-score or mid-upper arm circumference (MUAC) ≥ 125 mm
Moderate cute malnutrition is defined by Weight-for-height (WHZ) < - 2 z-score or mid-upper arm circumference (MUAC) < 125 mm. Higher WHZ z-score (≥ - 2) or mid-upper arm circumference (MUAC) ≥ 125 mm means better outcome synonym of recovery
Sustained recovery defined by WHZ ≥ - 2 z-score or MUAC ≥ 125 mm
Children who sustain recovery (WHZ ≥ - 2 z-score or MUAC ≥ 125 mm) up to 24 weeks

Secondary Outcome Measures

Mean change in Weight-for-height (WHZ) z-score
(WHZ z-score at admission) - (WHZ z-score at 12 weeks)
Mean change in Weight-for-age (WAZ) z-score
(WAZ z-score at admission) - (WAZ z-score at 12 weeks)
Mean change in Height-for-age (HAZ) z-score
(HAZ z-score at admission) - (HAZ z-score at 12 weeks)
Time to recovery
Determined by the number of days from admission to programmatic recovery among those who recovered
Dropouts
Lost to follow up
Non-response defined by WHZ < -2 z-score, or a MUAC < 125 mm
Children who failed to attain a weight-for-height (WHZ) ≥ - 2 z-score or mid-upper arm circumference (MUAC) ≥ 125 mm
Complications
Edema Fever >39°C or hypothermia <35°C Severe dehydration Repeated or incessant vomiting Severe respiratory problem (IMCI criteria) severe anemia (significant pallor with difficulty of breathing) Severe malaria Abscess or extensive skin lesions Very weak, apathetic, unconscious Seizure
Failure
Absence of weight gain, assessed at the 3rd consecutive visit; Weight loss since admission to the program, assessed at the 1st visit after admission; Loss of 5% of body weight compared to admission weight.

Full Information

First Posted
September 22, 2022
Last Updated
October 14, 2022
Sponsor
Institut de Recherche en Sciences de la Sante, Burkina Faso
Collaborators
Ministry of Health, Burkina Faso, Bill and Melinda Gates Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05586139
Brief Title
Microbiome-Directed Food for Sustained Recovery From Acute Malnutrition
Acronym
MDF
Official Title
Efficacy of a Food Targeting the Microbiota for a Sustained Recovery of Children With Uncomplicated Acute Malnutrition
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
January 16, 2023 (Anticipated)
Primary Completion Date
August 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institut de Recherche en Sciences de la Sante, Burkina Faso
Collaborators
Ministry of Health, Burkina Faso, Bill and Melinda Gates Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this experimental study is to test the efficacy of a new formulation - The microbiome-directed food (MDF) to treat acute malnutrition among children aged 6 to 23 months. The main questions it aims to answer are: Does treating children with moderate or severe uncomplicated malnutrition using MDF leads to higher programmatic recovery rate compared to standard of care ? Does treating children with moderate or severe uncomplicated malnutrition using MDF leads to higher sustained recovery rate compared to standard of care ? The MDF will be compared to Ready-to-use supplementary food (RUSF) and a locally available food (LAF) for moderately malnourished children, and to Ready-to-use therapeutic food (RUTF) for severely malnourished children to see the effects on recovery and sustained recovery rate.
Detailed Description
In this stratified trial, children presenting at the health center and fulfilling the inclusion criteria will randomly assigned to study groups. The supplementation will be done on daily basis according to the child's weight for a maximum of 12 weeks, at which point the recovery assessment is done. Each child will be subsequently followed up to 24 weeks for recovery assessment. Follow-up visits will be done at the health center every week for severe acute malnutrition (SAM) children and every two weeks for moderate acute malnutrition (SAM) children

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Malnutrition in Childhood

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Individually randomized and controlled trial, Stratified by severity of malnutrition: 2 arms for Severe Acute malnutrition 3 arms for Moderate acute Malnutrition
Masking
None (Open Label)
Allocation
Randomized
Enrollment
7100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Microbiome-directed food (MDF) - MAM
Arm Type
Experimental
Arm Description
Each (MAM) child will receive a daily ration of MDF corresponding to his weight, for maximum 12 weeks of supplementation
Arm Title
Ready-to-use supplementary food (RUSF)
Arm Type
Active Comparator
Arm Description
Each (MAM) child will receive a daily ration of MDF corresponding to his weight, for maximum 12 weeks of supplementation
Arm Title
Locally available Food
Arm Type
Active Comparator
Arm Description
Each (MAM) child will receive a basket of food ingredients to prepare a complementary food at home. The quantity of ingredients is based on child's weight. The food is given a maximum duration of 12 weeks.
Arm Title
Microbiome-directed food (MDF) - SAM
Arm Type
Experimental
Arm Description
Each (SAM) child will receive a daily ration of MDF corresponding to his weight, for maximum 12 weeks of supplementation.
Arm Title
Ready-to-use therapeutic food (RUTF)
Arm Type
Active Comparator
Arm Description
Each (SAM) child will receive a daily ration of RUTF corresponding to his weight, for maximum 12 weeks of supplementation
Intervention Type
Dietary Supplement
Intervention Name(s)
Microbiome-directed food - MAM
Other Intervention Name(s)
MDF - MAM
Intervention Description
Each MAM child will be supplemented with MDF for a maximum of 12 weeks. He will be followed subsequently up to 24 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Ready-to-use supplementary food (RUSF)
Other Intervention Name(s)
RUSF
Intervention Description
Each MAM child will be supplemented with RUSF for a maximum of 12 weeks. He will be followed subsequently up to 24 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Locally available food
Other Intervention Name(s)
LAF
Intervention Description
Each MAM child will consume a food made of locally available ingredients for a maximum of 12 weeks. He will be followed subsequently up to 24 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Microbiome-directed food (MDF) - SAM
Other Intervention Name(s)
MDF - SAM
Intervention Description
Each SAM child will be supplemented with MDF for a maximum of 12 weeks. He will be followed subsequently up to 24 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Ready-to-use therapeutic food (RUTF)
Other Intervention Name(s)
RUTF
Intervention Description
Each SAM child will be supplemented with RUTF for a maximum of 12 weeks. He will be followed subsequently up to 24 weeks.
Primary Outcome Measure Information:
Title
Programmatic recovery defined by Weight-for-height (WHZ) ≥ - 2 z-score or mid-upper arm circumference (MUAC) ≥ 125 mm
Description
Moderate cute malnutrition is defined by Weight-for-height (WHZ) < - 2 z-score or mid-upper arm circumference (MUAC) < 125 mm. Higher WHZ z-score (≥ - 2) or mid-upper arm circumference (MUAC) ≥ 125 mm means better outcome synonym of recovery
Time Frame
12th weeks from admission to the supplementation program
Title
Sustained recovery defined by WHZ ≥ - 2 z-score or MUAC ≥ 125 mm
Description
Children who sustain recovery (WHZ ≥ - 2 z-score or MUAC ≥ 125 mm) up to 24 weeks
Time Frame
24 weeks from admission to the supplementation program
Secondary Outcome Measure Information:
Title
Mean change in Weight-for-height (WHZ) z-score
Description
(WHZ z-score at admission) - (WHZ z-score at 12 weeks)
Time Frame
12 weeks from admission to the supplementation program
Title
Mean change in Weight-for-age (WAZ) z-score
Description
(WAZ z-score at admission) - (WAZ z-score at 12 weeks)
Time Frame
12 weeks from admission to the supplementation program
Title
Mean change in Height-for-age (HAZ) z-score
Description
(HAZ z-score at admission) - (HAZ z-score at 12 weeks)
Time Frame
12 weeks from admission to the supplementation program
Title
Time to recovery
Description
Determined by the number of days from admission to programmatic recovery among those who recovered
Time Frame
Up to 12 weeks
Title
Dropouts
Description
Lost to follow up
Time Frame
12 weeks
Title
Non-response defined by WHZ < -2 z-score, or a MUAC < 125 mm
Description
Children who failed to attain a weight-for-height (WHZ) ≥ - 2 z-score or mid-upper arm circumference (MUAC) ≥ 125 mm
Time Frame
12 weeks
Title
Complications
Description
Edema Fever >39°C or hypothermia <35°C Severe dehydration Repeated or incessant vomiting Severe respiratory problem (IMCI criteria) severe anemia (significant pallor with difficulty of breathing) Severe malaria Abscess or extensive skin lesions Very weak, apathetic, unconscious Seizure
Time Frame
up to 12 weeks
Title
Failure
Description
Absence of weight gain, assessed at the 3rd consecutive visit; Weight loss since admission to the program, assessed at the 1st visit after admission; Loss of 5% of body weight compared to admission weight.
Time Frame
up to 12 weeks
Other Pre-specified Outcome Measures:
Title
Cost-effectiveness
Description
Cost-effectiveness, as defined by the incremental cost per child cured according to the program and per child cured sustainedly
Time Frame
12 weeks; 24 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
23 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age between 6 and 23 months Moderate wasting: WHZ < -2 and ≥ -3 or MUAC < 125 mm and ≥ 115mm or - Severe wasting: WHZ < -3 or MUAC < 115 mm Exclusion Criteria: Bilateral pitting edema Not eating/lack of appetite Current illness medical complications requiring inpatient treatment Presence of any congenital abnormality or underlying chronic disease that may affect growth or risk of infection Known contraindication/hypersensitivity/allergy to MDCF of RUSF ingredients (chickpea flour, soy flour, banana, peanut) Relapse from MAM treatment or transfer from SAM treatment Children recently (<2 months) or enrolled in a nutrition program Residence outside the study area
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hermann Biènou LANOU, MD., PhD.
Phone
+226 66557580
Email
hlanou@yahoo.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Seni KOUANDA, MD., PhD
Phone
+226 70261462
Email
senikouanda@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Seni KOUANDA, MD., PhD
Organizational Affiliation
Institut de Recherche en Sciences de la Santé, Burkina-Faso
Official's Role
Principal Investigator
Facility Information:
Facility Name
LANOU Hermann Bienou
City
Ouagadougou
State/Province
Kadiogo
Country
Burkina Faso
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hermann Biènou LANOU, MD., PhD
Phone
+226 66557580
Email
hlanou@yahoo.ca
First Name & Middle Initial & Last Name & Degree
Seni KOUANDA, MD.,PhD
Phone
+226 70261462
Email
senikouanda@gmail.com
First Name & Middle Initial & Last Name & Degree
Hermann LANOU, PhD.
First Name & Middle Initial & Last Name & Degree
Jérôme SOME, PhD
First Name & Middle Initial & Last Name & Degree
Seni KOUANDA, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Microbiome-Directed Food for Sustained Recovery From Acute Malnutrition

We'll reach out to this number within 24 hrs